These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 19505813

  • 1. Tuberculosis vaccine research: the impact of immunology.
    Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [Abstract] [Full Text] [Related]

  • 2. A review of vaccine research and development: tuberculosis.
    Girard MP, Fruth U, Kieny MP.
    Vaccine; 2005 Dec 30; 23(50):5725-31. PubMed ID: 16153751
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 30; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 4. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST, Kaufmann SH.
    Int J Med Microbiol; 2008 Jan 30; 298(1-2):143-50. PubMed ID: 17702652
    [Abstract] [Full Text] [Related]

  • 5. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M, Kita Y.
    Kekkaku; 2010 Jun 30; 85(6):531-8. PubMed ID: 20662249
    [Abstract] [Full Text] [Related]

  • 6. Recent findings in immunology give tuberculosis vaccines a new boost.
    Kaufmann SH.
    Trends Immunol; 2005 Dec 30; 26(12):660-7. PubMed ID: 16246622
    [Abstract] [Full Text] [Related]

  • 7. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 8. Progress in tuberculosis vaccine development.
    Baumann S, Nasser Eddine A, Kaufmann SH.
    Curr Opin Immunol; 2006 Aug 12; 18(4):438-48. PubMed ID: 16777396
    [Abstract] [Full Text] [Related]

  • 9. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
    Rook GA, Hernández-Pando R, Zumla A.
    J Infect Dis; 2009 Mar 01; 199(5):613-8. PubMed ID: 19199549
    [Abstract] [Full Text] [Related]

  • 10. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J, Doherty TM.
    APMIS; 2009 May 01; 117(5-6):440-57. PubMed ID: 19400867
    [Abstract] [Full Text] [Related]

  • 11. Future vaccination strategies against tuberculosis: thinking outside the box.
    Kaufmann SH.
    Immunity; 2010 Oct 29; 33(4):567-77. PubMed ID: 21029966
    [Abstract] [Full Text] [Related]

  • 12. Advances in tuberculosis vaccine strategies.
    Skeiky YA, Sadoff JC.
    Nat Rev Microbiol; 2006 Jun 29; 4(6):469-76. PubMed ID: 16710326
    [Abstract] [Full Text] [Related]

  • 13. Adjuvants in tuberculosis vaccine development.
    Moreno-Mendieta SA, Rocha-Zavaleta L, Rodriguez-Sanoja R.
    FEMS Immunol Med Microbiol; 2010 Feb 29; 58(1):75-84. PubMed ID: 20002177
    [Abstract] [Full Text] [Related]

  • 14. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB, Kalra M, Verma I, Khuller GK.
    Clin Immunol; 2007 Mar 29; 122(3):239-51. PubMed ID: 17208519
    [Abstract] [Full Text] [Related]

  • 15. Fact and fiction in tuberculosis vaccine research: 10 years later.
    Kaufmann SH.
    Lancet Infect Dis; 2011 Aug 29; 11(8):633-40. PubMed ID: 21798463
    [Abstract] [Full Text] [Related]

  • 16. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R, Aguilar LD, Infante E, Cataldi A, Bigi F, Martin C, Gicquel B.
    Tuberculosis (Edinb); 2006 Aug 29; 86(3-4):203-10. PubMed ID: 16542875
    [Abstract] [Full Text] [Related]

  • 17. Novel tuberculosis vaccines on the horizon.
    Parida SK, Kaufmann SH.
    Curr Opin Immunol; 2010 Jun 29; 22(3):374-84. PubMed ID: 20471231
    [Abstract] [Full Text] [Related]

  • 18. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P.
    J Immunol; 2009 Jun 15; 182(12):8047-55. PubMed ID: 19494330
    [Abstract] [Full Text] [Related]

  • 19. Development of vaccines against tuberculosis.
    Tyagi AK, Nangpal P, Satchidanandam V.
    Tuberculosis (Edinb); 2011 Sep 15; 91(5):469-78. PubMed ID: 21334259
    [Abstract] [Full Text] [Related]

  • 20. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.
    Glatman-Freedman A.
    Tuberculosis (Edinb); 2006 Sep 15; 86(3-4):191-7. PubMed ID: 16584923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.